GlaxoSmithKline PLC ADR (NYSE:GSK) - Share price - Overview

Stock Report

GlaxoSmithKline PLC GSK

Last Price
$41.34

Day Change
0.42|1.03%

As of 17/02/2017
17:18:53 EST | USD
Minimum 15 Minutes Delay.

Last Close40.92
Day Range40.88 - 41.34
Mkt Cap100.70Bil
52-Wk Range37.20 - 45.58
Yield %5.04
ISINUS37733W1053
Volume4,272,870
P/E-
P/S3.05
P/CF16.21

Share Price

Financials
201320142015
More ...
Income Statement
Revenue26,505.0023,006.0023,923.00
Operating Income7,028.003,597.0010,322.00
Net Income5,436.002,756.008,422.00
Basic EPS2.251.153.49
Avg. Diluted Shares Outstanding2,4602,4332,444
Balance Sheet
Current Assets15,227.0014,678.0016,587.00
Non Current Assets26,859.0025,973.0036,859.00
Total Assets42,086.0040,651.0053,446.00
Current Liabilities13,677.0013,295.0013,417.00
Total Liabilities35,089.0036,388.0048,332.00
Total Equity6,997.004,263.005,114.00
Cash Flow
Operating Cash Flow7,222.005,176.002,569.00
Capital Expenditure-1,701.00-1,751.00-1,901.00
Free Cash Flow5,521.003,425.00668.00

In millions, except "Basic EPS". Currency is GBP.

Company Profile

GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including vaccines, over-the-counter (OTC) medicines and health-related consumer products.

Sector

Healthcare

Industry

Drug Manufacturers - Major

Stock Style

Large-Blend

Fiscal Year Ends

December

Employees

101,255
Key Stats
More ...
Price/Earning TTM-
Price/Book578.78
Price/Sales TTM-
Rev Growth (3 year avg)-3.27
EPS Growth (3 year avg)-
Operating Margin % TTM43.15
Net Margin % TTM35.20
ROE TTM179.63
Debt/Equity3.00
Dividends
PreviousLatest
More ...
Declared Date31/10/1608/02/17
Ex-Div02/11/1622/02/17
Paid12/01/1716/04/17
Amnt0.460.58
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.